Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. The Study Group of Primary Prophylaxis
- PMID: 1526413
Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. The Study Group of Primary Prophylaxis
Abstract
Beta blockers are effective in the prevention of first bleeding of esophageal varices in cirrhotic patients; however, the bleeding incidence is reduced by only 20 percent. This study was aimed at investigating the factors associated with the occurrence of first bleeding and death rate in patients receiving propranolol for primary prevention. One hundred and nine patients were included in the study, 92 percent of whom were alcoholic. According to Child-Pugh's classification, the distribution was grade A: 16 percent, grade B: 36 percent, grade C: 48 percent. During the study, 18 patients bled and 21 died. In survivors without bleeding, the median follow-up was 14 months. The predictive value of 34 biochemical or clinical variables, recorded at entry or during the course of the study, was first tested using univariate analysis. A higher initial Child-Pugh score and a smaller decrease in Child-Pugh score during the study were significantly associated with an increased bleeding risk; the above factors along with a low initial value and a higher decrease in plasma sodium concentration during the study were significantly associated with an increased death rate. Next, we tested these factors as well as others with potential explicative value, using multivariate analysis according to a multiple regression model.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.N Engl J Med. 1987 Oct 1;317(14):856-61. doi: 10.1056/NEJM198710013171403. N Engl J Med. 1987. PMID: 3306385 Clinical Trial.
-
[Predictive factors of the first digestive hemorrhage and death in cirrhotic patients with esophageal varices].Gastroenterol Clin Biol. 1989 Jan;13(1):54-9. Gastroenterol Clin Biol. 1989. PMID: 2784397 French.
-
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.N Engl J Med. 1991 May 30;324(22):1532-8. doi: 10.1056/NEJM199105303242202. N Engl J Med. 1991. PMID: 1674104 Clinical Trial.
-
[Prognosis and prognostic factors of hemorrhage by rupture of varices in cirrhotic patients in the era of endoscopic sclerotherapy].Gastroenterol Clin Biol. 1991;15(11):838-44. Gastroenterol Clin Biol. 1991. PMID: 1769474 Review. French.
-
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].Gastroenterol Clin Biol. 1988 Dec;12(12):899-905. Gastroenterol Clin Biol. 1988. PMID: 3069544 Review. French.
Cited by
-
Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD004544. doi: 10.1002/14651858.CD004544.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical